tiprankstipranks
Advertisement
Advertisement

NVNO Stock Latest News

enVVeno Medical files $100M mixed securities shelf
The FlyenVVeno Medical files $100M mixed securities shelf
4h ago
NVNO
enVVeno announces publication of independent health economic study
PremiumThe Fly
enVVeno announces publication of independent health economic study
17d ago
NVNO
enVVeno Medical reports Q2 EPS ($5.37) vs. ($11.52) last year
PremiumThe Fly
enVVeno Medical reports Q2 EPS ($5.37) vs. ($11.52) last year
21d ago
NVNO
enVVeno Medical sees cash runway into 3Q27
PremiumThe Fly
enVVeno Medical sees cash runway into 3Q27
21d ago
NVNO
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2H26
PremiumThe Fly
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2H26
21d ago
NVNO
enVVeno Medical highlights newly issued U.S. patent
PremiumThe FlyenVVeno Medical highlights newly issued U.S. patent
1M ago
NVNO
enVVeno Medical Updates Investors With New Presentation
Premium
Company Announcements
enVVeno Medical Updates Investors With New Presentation
1M ago
8K
NVNO
enVVeno Medical secures U.S. patent for enVVe system
Premium
The Fly
enVVeno Medical secures U.S. patent for enVVe system
2M ago
NVNO
enVVeno Medical upgraded to Buy from Neutral at Ladenburg
PremiumThe Fly
enVVeno Medical upgraded to Buy from Neutral at Ladenburg
2M ago
NVNO
enVVeno Medical reports Q1 EPS ($5.89) vs. ($7.75) last year
PremiumThe Fly
enVVeno Medical reports Q1 EPS ($5.89) vs. ($7.75) last year
4M ago
NVNO
enVVeno Medical sees cash runway into 3Q27
PremiumThe Fly
enVVeno Medical sees cash runway into 3Q27
4M ago
NVNO
enVVeno Medical says cash burn rate may increase to $4M-$5M per quarter
PremiumThe Fly
enVVeno Medical says cash burn rate may increase to $4M-$5M per quarter
4M ago
NVNO
enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study
PremiumThe FlyenVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study
4M ago
NVNO
enVVeno Medical Wins FDA IDE for TAVVE Trial
Premium
Company Announcements
enVVeno Medical Wins FDA IDE for TAVVE Trial
4M ago
8K
NVNO
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year
Premium
The Fly
enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year
5M ago
NVNO
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026
PremiumThe Fly
enVVeno Medical expects cash burn rate of $4M-$5M per quarter in 2026
5M ago
NVNO
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO)
PremiumAI Analyst Ratings
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO)
5M ago
NVNO
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans
PremiumCompany Announcements
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans
7M ago
8K
NVNO
enVVeno Medical regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
enVVeno Medical regains compliance with Nasdaq minimum bid price rule
7M ago
NVNO
enVVeno Medical Executes One-for-35 Reverse Stock Split
PremiumCompany AnnouncementsenVVeno Medical Executes One-for-35 Reverse Stock Split
7M ago
8K
NVNO
Upcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
Premium
Market News
Upcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
7M ago
PBM
BTOG
enVVeno Medical trading halted, news pending
Premium
The Fly
enVVeno Medical trading halted, news pending
7M ago
NVNO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >